Hair Loss in Men: Causes, Treatments, and What Actually Works
Most men will experience noticeable hair loss at some point in their lives. It is not a question of if, but when and how much. Research from Andrology Australia estimates that roughly two-thirds of Australian men experience appreciable hair loss by the age of 35, and by 80, that figure climbs to around 80 percent. These are not outlier statistics. They describe the majority.
Yet the experience of losing your hair rarely feels like something the majority goes through. It feels personal. It affects how you see yourself in the mirror, in photographs, in work meetings, on dates. For many men, hair loss is tied not just to appearance but to a sense of control over their own body. The frustration is real, and it is made worse by an industry flooded with products that promise everything and deliver very little.
This article is a straightforward, evidence-based guide to understanding why men lose their hair, which treatments have genuine clinical support, and what is not worth your time or money. Everything here is grounded in Australian clinical guidelines and peer-reviewed research, reviewed by our Chief Medical Officer Dr Ramu Nachiappan.
If you have been Googling hair loss treatments at midnight and feeling overwhelmed by conflicting information, this is the guide that cuts through it.
Androgenetic Alopecia (Male Pattern Baldness)
The overwhelming majority of male hair loss is androgenetic alopecia, commonly called male pattern baldness. It accounts for approximately 95 percent of hair loss in men, according to Healthdirect Australia.
The mechanism is hormonal. Testosterone is converted into dihydrotestosterone (DHT) by an enzyme called 5-alpha reductase. In men with a genetic predisposition, DHT binds to receptors in the hair follicles of the scalp, causing them to miniaturise over time. The follicles produce thinner, shorter hairs with each growth cycle until they eventually stop producing visible hair altogether. This process typically follows a recognisable pattern: a receding hairline at the temples and thinning at the crown, gradually progressing over years or decades.
The genetic component is significant. If your father or maternal grandfather experienced pattern baldness, you are more likely to as well. However, the inheritance pattern is complex and involves multiple genes, so family history is not a perfect predictor.
Telogen Effluvium (Stress-Related Hair Loss)
Telogen effluvium is a form of temporary, diffuse hair shedding triggered by a significant physical or emotional stressor. This can include major illness, surgery, severe psychological stress, rapid weight loss, or nutritional deficiency. The hair loss typically appears two to three months after the triggering event and usually resolves on its own once the underlying cause is addressed.
Alopecia Areata
Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, causing patchy hair loss that can appear suddenly. It affects roughly two percent of the population and can occur at any age. The patches are usually round and well-defined. Treatment options exist, and a GP can provide referral to a dermatologist for management.
Other Contributing Factors
Several other factors can contribute to or accelerate hair loss in men. These include iron deficiency, zinc deficiency, vitamin D deficiency, thyroid disorders (both hypothyroidism and hyperthyroidism), certain medications (including some blood pressure medications, anticoagulants, and antidepressants), and chronic scalp conditions. A comprehensive clinical assessment can identify whether any of these are playing a role.
The single most important thing to understand about treating hair loss is that earlier intervention produces better outcomes. The treatments with the strongest clinical evidence work by slowing further loss and, in some cases, promoting regrowth. They are most effective when hair follicles are still active rather than permanently miniaturised.
If you are noticing a gradually receding hairline or thinning at the crown, that is worth a conversation with a GP. You do not need to wait until the loss is advanced. In fact, waiting is the one decision most men later regret.
Sudden or patchy hair loss warrants a more prompt assessment. Rapid shedding, bald patches that appear over days or weeks, or hair loss accompanied by other symptoms such as fatigue, weight changes, or skin changes may indicate an underlying condition that requires investigation.
A GP consultation is the appropriate starting point. Your doctor can assess the pattern of loss, review your medical history and medications, and order blood tests to check for nutritional deficiencies, thyroid dysfunction, or hormonal imbalances. In some cases, referral to a dermatologist may be appropriate for further assessment, including scalp biopsy or trichoscopy.
Hair loss is not something you need to simply accept. But it is something that benefits from a clinical conversation rather than a Google search and an impulse purchase.
There are two medications with strong, well-established clinical evidence for treating male pattern baldness. Beyond those, a handful of other options have varying levels of support. Here is an honest overview.
Minoxidil (Topical)
Minoxidil is an over-the-counter topical treatment available as a solution or foam, applied directly to the scalp. In Australia, it is classified as a Schedule 5 medication and can be purchased from pharmacies without a prescription.
Minoxidil works by increasing blood flow to the hair follicles and prolonging the growth phase of the hair cycle. It does not address the underlying hormonal cause of androgenetic alopecia but can help slow hair loss and, in some individuals, promote modest regrowth. A Cochrane systematic review found that topical minoxidil was more effective than placebo at promoting hair regrowth, with the five percent formulation generally showing greater effect than the two percent formulation.
Results are not immediate. Clinical trials suggest that consistent daily use for at least four to six months is needed before meaningful changes become visible. If minoxidil is stopped, any hair maintained by the treatment will typically be lost within a few months. Common side effects include scalp irritation and, less frequently, unwanted facial hair growth from inadvertent transfer of the product.
Finasteride (Oral, Prescription)
Finasteride is an oral prescription medication that works by inhibiting the 5-alpha reductase enzyme, thereby reducing the conversion of testosterone to DHT. By lowering scalp DHT levels, finasteride slows follicle miniaturisation and can, over time, lead to some degree of regrowth.
The evidence base for finasteride is robust. A landmark study published in the Journal of the American Academy of Dermatology demonstrated that finasteride at a dose of 1mg daily significantly increased hair count compared with placebo over a two-year period. Long-term follow-up studies have shown sustained benefit over five years of continuous use.
Your GP may prescribe finasteride after a thorough clinical assessment. It is important to discuss the full side effect profile, which includes a small but documented risk of sexual side effects such as decreased libido, erectile difficulty, and reduced ejaculate volume. These side effects are uncommon, affecting a small percentage of men in clinical trials, and are generally reversible upon discontinuation. However, reports of persistent side effects in a small number of individuals have been noted in the medical literature, and this is something your GP can discuss with you in the context of your individual circumstances.
Finasteride is a Schedule 4 prescription medication in Australia. It requires ongoing GP monitoring, which is an appropriate part of responsible treatment.
Combination Therapy
Clinical evidence suggests that using minoxidil and finasteride together may produce better outcomes than either treatment alone. A study published in Dermatologic Surgery found that combination therapy resulted in greater improvement in hair density compared with monotherapy. Your GP can advise whether this approach is suitable for you.
Low-Level Laser Therapy (LLLT)
Low-level laser therapy devices, including laser combs and caps, are marketed for hair loss treatment. Some clinical studies have shown a modest improvement in hair density, but the evidence remains limited and the quality of many studies is variable. LLLT is not considered a first-line treatment and is generally viewed as a potential adjunct rather than a standalone option.
Platelet-Rich Plasma (PRP) Therapy
PRP therapy involves injecting concentrated platelets from your own blood into the scalp. Early research has shown some promise, but the evidence base is still emerging. Study designs vary widely, and there is no standardised protocol. PRP is not a first-line treatment and is not typically covered by Medicare. If you are considering it, discuss the current evidence with your GP or dermatologist.
Hair Transplant Surgery
For men with stable, advanced hair loss who have not responded adequately to medical therapy, surgical hair transplantation is an option. Modern techniques, including follicular unit extraction (FUE), can produce natural-looking results. This is a specialist procedure, and your GP can provide a referral to an appropriately qualified surgeon. Medical treatment is often recommended alongside transplantation to help maintain non-transplanted hair.
The hair loss industry is enormous, and a significant portion of it relies on hope rather than evidence. Being direct about what does not work can save you considerable money and frustration.
Biotin supplements are widely marketed for hair growth. However, there is no clinical evidence that biotin supplementation improves hair loss in individuals who are not biotin-deficient. Biotin deficiency is rare in people eating a balanced diet. Unless a blood test has confirmed a deficiency, biotin supplements are unlikely to make a difference.
Most over-the-counter "hair growth" serums, shampoos, and tonics lack rigorous clinical evidence. Products claiming to "strengthen" hair, "nourish follicles," or "block DHT naturally" with botanical extracts have generally not been tested in well-designed clinical trials. Some may improve the cosmetic appearance of existing hair, but that is not the same as treating hair loss.
Scalp massage devices and derma rollers have limited and preliminary evidence. While some small studies have explored microneedling as an adjunct to minoxidil, the evidence is not yet sufficient to recommend it as a standalone treatment.
The most effective approach is to start with the treatments that have the strongest evidence behind them, guided by a GP who can tailor a plan to your specific situation.
Ready to talk to a doctor?
Hair loss is a clinical condition, and the most effective treatments require either a prescription or a clinical assessment to rule out underlying causes. The challenge for many men is not a lack of willingness to seek help. It is finding the time and, frankly, the privacy to do so.
Abby Health consultations are conducted via secure telehealth with a GP who is part of a care network of over 300 clinicians, available seven days a week, 365 days a year. There is no waiting room, no explaining your reason for visiting to a receptionist, and no need to take time off work. You can have the consultation from wherever suits you.
Your GP can assess your hair loss pattern, review your medical history, order blood tests to investigate potential underlying causes such as thyroid dysfunction or nutritional deficiencies, and prescribe treatment if clinically appropriate. Because Abby Health is built around continuity of care, follow-up appointments and treatment monitoring can happen with the same GP who knows your history.
Consultations can be bulk billed for eligible patients, and appointments are available at times that fit around your schedule.
If you are also interested in other men's health topics, our guides on erectile dysfunction: causes, treatment, and how to talk to your GP and STI testing for men in Australia cover those clinical pathways in the same evidence-based approach.
Hair loss is not something you have to live with in silence, and it is not something to be embarrassed about. It is one of the most common health concerns affecting Australian men, and the earlier it is addressed, the more options are available.
A GP consultation is the starting point. It is a conversation, not a commitment. It is a chance to understand what is happening, explore treatment options that have genuine clinical evidence, and make informed decisions about your own health with a clinician who understands your full story.
You deserve care that understands you.
Editorial Standards
Notice something that doesn’t look right? Let us know at support@abbyhealth.app
- Andrology Australia (Healthy Male). (2024). Hair Loss (Androgenetic Alopecia) Fact Sheet. Monash University. https://www.healthymale.org.au/health-conditions/hair-loss
- Healthdirect Australia. (2024). Male Pattern Baldness. Australian Government Department of Health. https://www.healthdirect.gov.au/male-pattern-baldness
- Varothai, S., & Bergfeld, W.F. (2014). "Androgenetic alopecia: an evidence-based treatment update." American Journal of Clinical Dermatology, 15(3), 217-230.
- Kaufman, K.D., Olsen, E.A., Whiting, D., et al. (1998). "Finasteride in the treatment of men with androgenetic alopecia." Journal of the American Academy of Dermatology, 39(4), 578-589.
- Olsen, E.A., Dunlap, F.E., Funicella, T., et al. (2002). "A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men." Journal of the American Academy of Dermatology, 47(3), 377-385.
- Rossi, A., Cantisani, C., Melis, L., et al. (2012). "Minoxidil use in dermatology, side effects and recent patents." Recent Patents on Inflammation & Allergy Drug Discovery, 6(2), 130-136.
- Hu, R., Xu, F., Sheng, Y., et al. (2015). "Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients." Dermatologic Surgery, 41(6), 737-740.
- DermNet NZ. (2024). Androgenetic Alopecia. DermNet New Zealand Trust. https://dermnetnz.org/topics/androgenetic-alopecia
- Royal Australian College of General Practitioners (RACGP). (2024). Guidelines for preventive activities in general practice (Red Book). 10th edition. East Melbourne: RACGP.
- Adil, A., & Godwin, M. (2017). "The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis." Journal of the American Academy of Dermatology, 77(1), 136-141.




%20Medium.jpeg)










